0001950047-23-005924.txt : 20231212 0001950047-23-005924.hdr.sgml : 20231212 20231212164006 ACCESSION NUMBER: 0001950047-23-005924 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 231481713 BUSINESS ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Velleca Mark A. CENTRAL INDEX KEY: 0001706847 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 79 TW ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 144 1 primary_doc.xml 144 0001706847 XXXXXXXX LIVE 0001560241 G1 THERAPEUTICS, INC. 001-38096 700 Park Offices Drive, Suite 200 Research Triangle Park NC 27709 (919) 213-9835 MARK VELLECA Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

60000 203916.00 51843669 12/12/2023 NASDAQ Common 12/12/2023 Stock Option Exercise Issuer N 60000 12/12/2023 Cash Y 12/12/2023 05/05/2023 /s/ Mark Albert Velleca